Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-17 · accession 0001567619-22-011342 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-19 | 2022-05-17 | TMCI | Jain Deepti | Dir | A - Grant | $0.00 | +3,482 | 1,187 | New | $0 |
| DM | 2022-05-19 | 2022-05-17 | TMCI | Jain Deepti | Dir | A - Grant | $0.00 | +25.2K | 16.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-17 | A | A | 2,295 | $0.00 | 3,482 | D | — | — | (F2) Represents RSUs for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date. |
| 2 | Common | Common Stock | 2022-05-17 | A | A | 1,187 | $0.00 | 1,187 | D | — | — | (F1) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will vest in three equal yearly installments starting May 17, 2023 such that the RSUs will be fully vested on May 17, 2025 subject to Reporting Person's providing continued service to Issuer through each vesting date. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-05-17 | A | A | 8,600 | $0.00 | 8,600 | D | $15.80 · — to 2032-05-17 | 8,600 Common Stock | (F3) The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on June 17, 2022 such that the stock option will be fully vested and exercisable on May 17, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-05-17 | A | A | 16,625 | $0.00 | 16,625 | D | $15.80 · — to 2032-05-17 | 16,625 Common Stock | (F4) The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date. |